文献速递免疫规划传染病防控与疫情报告

多肽嵌合疫苗联合佐剂系统免疫预防可促进Th1反应并控制内脏利什曼病仓鼠模型的脾脏寄生虫负荷

Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis.
PubMed 文献 · Vaccine · 2022-08-10

研究评估两种预测的T细胞多表位嵌合疫苗联合佐剂系统在金黄仓鼠内脏利什曼病模型中的免疫反应。两种嵌合疫苗均诱导以Th1为主的免疫应答,增加IFN-γ和TNF-α产生并减少IL-10,同时降低脾脏寄生虫负荷和重量。结果证明两种嵌合疫苗具有免疫原性,与小鼠模型结果一致。

要点

  • 两种嵌合疫苗均诱导 dominant Th1 反应,增加 IFN-γ 和 TNF-α 并减少 IL-10。
  • 两种嵌合疫苗均降低脾脏寄生虫负荷和脾脏重量。
  • 结果与小鼠模型一致,支持仓鼠作为犬和人内脏利什曼病疫苗临床前模型。

核心结论

  • 两种嵌合疫苗均具有免疫原性,并印证了小鼠模型中的发现。
  • 研究强化了仓鼠作为犬和人内脏利什曼病疫苗试验临床前模型的用途。
  • 研究强调了免疫信息学在识别表位以设计该被忽视疾病疫苗方面的重要性。

研究设计与样本

  • 在金黄仓鼠(Mesocricetus auratus)内脏利什曼病模型中评估两种预测的T细胞多表位嵌合疫苗的免疫反应。
  • 仓鼠实验上呈现与人和犬内脏利什曼病相似的病理状态。
  • 两种嵌合疫苗此前已在BALB/c小鼠中实验验证免疫原性、中枢和效应记忆及抗内脏利什曼病保护作用。

主要发现

  • 两种嵌合疫苗均导致以Th1为主的反应谱,通过增加IFN-γ和TNF-α产生诱导强细胞反应,并伴随IL-10减少。
  • 两种嵌合疫苗均降低脾脏寄生虫负荷和重量。
  • 观察到保护性免疫机制与寄生虫负荷持续降低之间的相关性。

临床怎么用

  • 作者认为,结果强化了仓鼠作为犬和人内脏利什曼病疫苗试验临床前模型的用途。
  • 作者认为,免疫信息学对识别表位以设计该重要被忽视疾病疫苗具有重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In recent years, several advances have been observed in vaccinology especially for neglected tropical diseases (NTDs). One of the tools employed is epitope prediction by immunoinformatic approaches that reduce the time and cost to develop a vaccine. In this scenario, immunoinformatics is being more often used to develop vaccines for NTDs, in particular visceral leishmaniasis (VL) which is proven not to have an effective vaccine yet. Based on that, in a previous study, two predicted T-cell multi-epitope chimera vaccines were experimentally validated in BALB/c mice to evaluate the immunogenicity, central and effector memory and protection against VL. Considering the results obtained in the mouse model, we assessed the immune response of these chimeras inMesocricetus auratushamster, which displays, experimentally, similar pathological status to human and dog VL disease. Our findings indicate that both chimeras lead to a dominant Th1 response profile, inducing a strong cellular response by increasing the production of IFN-γ and TNF-α cytokines associated with a decrease in IL-10. Also, the chimeras reduced the spleen parasite load and the weight a correlation between protector immunological mechanisms and consistent reduction of the parasitic load was observed. Our results demonstrate that both chimeras were immunogenic and corroborate with findings in the mouse model. Therefore, we reinforce the use of the hamster as a pre-clinical model in vaccination trials for canine and human VL and the importance of immunoinformatic to identify epitopes to design vaccines for this important neglected disease.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gusmão MR, Ostolin TLVDP, Carvalho LM, et al. Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis. Vaccine. 2022. PMID: 35963820. doi:10.1016/j.vaccine.2022.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。